Table 3.
Complication | Neoadjuvant Group (n = 23) |
Non-Neoadjuvant Group (n = 230) |
χ2 | p |
---|---|---|---|---|
Air leak > 5 days | 9 (39.13%) | 125 (35.21%) | 100.42 | <0.001 |
Pneumothorax | 0 | 28 (7.89%) | 28 | <0.001 |
Subcutaneous emphysema | 1 (4.35%) | 26 (7.32%) | 23.15 | <0.001 |
Pleural/pulmonary infection | 1 (4.35%) | 23 (6.48%) | 20.17 | <0.001 |
Wound infection | 0 | 1 (0.28%) | 1 | 0.32 |
Respiratory insufficiency | 0 | 7 (1.97%) | 7 | 0.01 |
Hemothorax | 0 | 5 (1.41%) | 5 | 0.03 |
Myocardial infarction | 0 | 0 | ||
Postoperative atrial fibrillation | 2 (8.7%) | 9 (2.54%) | 4.45 | 0.03 |
Ischemia/Stroke | 0 | 6 (1.69%) | 6 | 0.01 |
Phrenic nerve injury | 0 | 2 (0.56%) | 2 | 0.16 |
Bronchio-pleural fistula | 0 | 5 (1.41%) | 5 | 0.03 |
Chylothorax | 0 | 4 (1.13%) | 4 | 0.05 |
Reintervention | 0 | 5 (1.41%) | 5 | 0.03 |
Readmission within 30 days | 0 | 24 (6.76%) | 24 | <0.001 |
Mortality | 0 | 4 (1.13%) | 4 | 0.05 |